Longeveron Inc. Common Stock (LGVN) is a publicly traded Healthcare sector company. As of September 3, 2026, LGVN trades at $6.75 with a market cap of $21.52M and a P/E ratio of -2.60. LGVN moved +0.00% today. Year to date, LGVN is +14.33%; over the trailing twelve months it is -16.90%. Its 52-week range spans $4.75 to $19.20. Analyst consensus is buy with an average price target of $3.00. Rallies surfaces LGVN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest LGVN news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $6.75 |
| Market Cap | $21.52M |
| P/E Ratio | -2.60 |
| EPS | $-2.62 |
| Dividend Yield | 0.00% |
| 52-Week High | $19.20 |
| 52-Week Low | $4.75 |
| Volume | 13.39K |
| Avg Volume | 0 |
| Revenue (TTM) | $2.39M |
| Net Income | $-15.97M |
| Gross Margin | 78.76% |
2 analysts cover LGVN: 0 strong buy, 1 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $3.00.